# A Trial Comparing MICARDIS® (Telmisartan) and COZAAR® / LORZAAR® (Losartan) in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring (ABPM)

> **NCT02200653** · PHASE4 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 387 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** High dose of MICARDIS®, once daily
- **DRUG:** Low dose of MICARDIS®, once daily
- **DRUG:** Low dose of COZAAR® / LORZAAR®, once daily
- **DRUG:** High dose of COZAAR® / LORZAAR®, once daily
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02200653
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-05
- **Primary completion:** 2001-02
- **Final completion:** —
- **Target enrollment:** 387 (ACTUAL)
- **Last updated:** 2014-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02200653

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02200653, "A Trial Comparing MICARDIS® (Telmisartan) and COZAAR® / LORZAAR® (Losartan) in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring (ABPM)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02200653. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*